|
Take heed to this text |
Horizon Surgical has established itself as a trusted authority in ensuring the precision and consistency of ophthalmological procedures. Supply: Adobe Inventory
Horizon Surgical Techniques Inc., a pioneer in merging synthetic intelligence and robotics to revolutionize microsurgery, announced the successful closure of a $30 million Series A funding round. The privately held micro-robotics company intends to utilize the funding to further develop its expertise platform, advance in-human studies, and expand its team.
“Notably, our group and trading partners recognize that Polaris is well-positioned to capitalize on the next phase in surgical robotics, effectively amplifying the surgeon’s skills through cutting-edge augmented visualization and precise robotic control,” said Jean-Pierre Hubschman, M.D., founder and CEO of Horizon.
“As artificial intelligence evolves in surgical robotics, it has the potential to revolutionize surgical assistance within the Polaris platform, enabling unparalleled precision, efficiency, and results in the operating room.”
Horizon Surgical develops Polaris
Horizon Surgical Techniques was spun out of UCLA in 2021. Its flagship Polaris platform leverages advanced medical imaging technologies and artificial intelligence to significantly enhance the abilities of ophthalmic surgeons for a range of eye procedures.
The California-based healthcare organization proclaimed that its assistive programs are designed to enhance the accessibility of quality care for all individuals. As one-quarter of the population develops cataracts over their lifetime, Polaris assures unparalleled precision, bolstering a scarcity of human expertise while concurrently streamlining recovery times.
ExSight Ventures joins board
ExSight Ventures and a significant company investor collaborated to lead the financing of Horizon Surgical Techniques. Primary Avenue Advisors, along with the University of California through its investment arm UC Investments, and other entities participated.
ExSight Ventures invests in early-stage companies developing innovative ophthalmic diagnostic and therapeutic solutions. The organization is led by two renowned retinal surgeons and supports the development of innovative biotechnology, medical devices, prescription medications, and software solutions specifically for the field of ophthalmology.
As well as, Firas M. Dr. Rahhal, Founder and Co-Associate of ExSight Ventures, alongside William A. Dr. Hyperlink has been appointed to Horizon’s board of directors.
Dr. Hyperlink specializes in early-stage investments within the biopharma and medical device industries. As the founder and managing associate of Flying L., he drives the organization’s strategic direction and oversees key initiatives. As Companions and a founder and managing director of Versant Ventures. Dr. As founder, chairman, and CEO of Chiron Imaginative and prescient, Hyperlink spearheaded the company’s growth before its acquisition by Bausch and Lomb in 1997.
Prior to the launch of Chiron Imaginative and Prescient, Dr. As the President of American Medical Optics (AMO), a subsidiary of American Hospital Supply Company, I oversaw the company’s operations until its acquisition by Allergan in 1986. After serving on the board of AMO’s successor firm, Superior Medical Optics, he continued his tenure until it was acquired by Abbott in 2009, followed by a subsequent acquisition by Johnson & Johnson in 2016.
I’m delighted to take on this new challenge, inspired by my colleague and friend, Dr. Jean-Pierre Hubaux, pioneer in the conception of this groundbreaking technology and medical innovation, renowned Dr. Rahhal.
“Robotic cataract surgery makes perfect sense,” he noted. Will the Horizon system, in my opinion, enable surgeons to operate more consistently and efficiently, with significantly fewer complications? We anticipate that this expertise will bring about even more reliable, user-friendly, and secure benefits for our patients in the years to come.
ExSight co-founder, Dr. Following their establishment of ExSight Ventures, Michael Nissen observed that surgical robotics stood out as a pioneering area. What’s next in ophthalmic surgery is being pioneered by Horizon Robotics, charting a definitive path towards a brighter future. The advancement in surgical procedures will significantly improve predictability and safety within the field of ophthalmology.
